Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qingwei Ji

Showing results (21-30 of 84) with videos related to

Pageof 9
Sort By:
Oxidative Medicine and Cellular Longevity|February 25, 2021
Anti-Interleukin-16 Neutralizing Antibody Treatment Alleviates Sepsis-Induced Cardiac Injury and Dysfunction via the Nuclear Factor Erythroid-2 Related Factor 2 Pathway in MiceJianwei Zhang, Zicong Yang, Zhishan Liang, et al.
Clinical Immunology (Orlando, Fla.)|September 9, 2023
Latency-associated peptide (LAP)<sup>+</sup>CD4<sup>+</sup> regulatory T cells prevent atherosclerosis by modulating macrophage polarizationJian Yu, Wenbin Xu, Qian Dong, et al.
Mediators of Inflammation|May 9, 2022
Corrigendum to "Anti-Interleukin-16-Neutralizing Antibody Attenuates Cardiac Inflammation and Protects against Cardiac Injury in Doxorubicin-Treated Mice"Jianwei Zhang, Zicong Yang, Zhishan Liang, et al.
European Journal of Pharmacology|April 1, 2022
Secreted frizzled-related protein 4 exerts anti-atherosclerotic effects by reducing inflammation and oxidative stressJianwei Zhang, Zicong Yang, Zhishan Liang, et al.
Mediators of Inflammation|May 7, 2021
Anti-Interleukin-16-Neutralizing Antibody Attenuates Cardiac Inflammation and Protects against Cardiac Injury in Doxorubicin-Treated MiceJianwei Zhang, Zicong Yang, Zhishan Liang, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|December 15, 2015
[Association between ABO blood groups and coronary heart disease in Chinese Guangxi Zhuang population]Ying Shi, Yingzhong Lin, Hairun Liu, et al.
Disease Markers|August 1, 2017
Circulating Th1, Th2, and Th17 Levels in Hypertensive PatientsQingwei Ji, Guojie Cheng, Ning Ma, et al.
Mediators of Inflammation|September 28, 2018
Circulating Th1, Th2, Th9, Th17, Th22, and Treg Levels in Aortic Dissection PatientsJing Ye, Yuan Wang, Zhen Wang, et al.
Medicine|December 20, 2019
Effects of circulating levels of Th17 cells on the outcomes of acute Stanford B aortic dissection patients after thoracic endovascular aortic repair: A 36-month follow-up study a cohort studyHongtao Liu, Ting Xiao, Le Zhang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 6, 2023
Inhibiting the MAPK pathway improves heart failure with preserved ejection fraction induced by salt-sensitive hypertensionShicheng Li, Ying Shi, Shanshan Yuan, et al.
Pageof 9

Showing results (21-30 of 84) with videos related to

Sort By:
Pageof 9
Oxidative Medicine and Cellular Longevity|February 25, 2021
Anti-Interleukin-16 Neutralizing Antibody Treatment Alleviates Sepsis-Induced Cardiac Injury and Dysfunction via the Nuclear Factor Erythroid-2 Related Factor 2 Pathway in MiceJianwei Zhang, Zicong Yang, Zhishan Liang, et al.
Clinical Immunology (Orlando, Fla.)|September 9, 2023
Latency-associated peptide (LAP)<sup>+</sup>CD4<sup>+</sup> regulatory T cells prevent atherosclerosis by modulating macrophage polarizationJian Yu, Wenbin Xu, Qian Dong, et al.
Mediators of Inflammation|May 9, 2022
Corrigendum to "Anti-Interleukin-16-Neutralizing Antibody Attenuates Cardiac Inflammation and Protects against Cardiac Injury in Doxorubicin-Treated Mice"Jianwei Zhang, Zicong Yang, Zhishan Liang, et al.
European Journal of Pharmacology|April 1, 2022
Secreted frizzled-related protein 4 exerts anti-atherosclerotic effects by reducing inflammation and oxidative stressJianwei Zhang, Zicong Yang, Zhishan Liang, et al.
Mediators of Inflammation|May 7, 2021
Anti-Interleukin-16-Neutralizing Antibody Attenuates Cardiac Inflammation and Protects against Cardiac Injury in Doxorubicin-Treated MiceJianwei Zhang, Zicong Yang, Zhishan Liang, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|December 15, 2015
[Association between ABO blood groups and coronary heart disease in Chinese Guangxi Zhuang population]Ying Shi, Yingzhong Lin, Hairun Liu, et al.
Disease Markers|August 1, 2017
Circulating Th1, Th2, and Th17 Levels in Hypertensive PatientsQingwei Ji, Guojie Cheng, Ning Ma, et al.
Mediators of Inflammation|September 28, 2018
Circulating Th1, Th2, Th9, Th17, Th22, and Treg Levels in Aortic Dissection PatientsJing Ye, Yuan Wang, Zhen Wang, et al.
Medicine|December 20, 2019
Effects of circulating levels of Th17 cells on the outcomes of acute Stanford B aortic dissection patients after thoracic endovascular aortic repair: A 36-month follow-up study a cohort studyHongtao Liu, Ting Xiao, Le Zhang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 6, 2023
Inhibiting the MAPK pathway improves heart failure with preserved ejection fraction induced by salt-sensitive hypertensionShicheng Li, Ying Shi, Shanshan Yuan, et al.
Pageof 9